BioSpace News Archive

Blood components are the products derived from platelet-rich plasma or whole blood.

Podiatrists are physicians or surgeons trained in preventing, diagnosing, and treating conditions of lower extremities such as feet and ankles

Urethritis is an inflammation of the urethra. It shows numerous symptoms, such as pain during urination and an increased urge to urinate.

On August 2, 2021, the US Food and Drug Administration approved the drug anifrolumab (Saphnelo) for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE) who are receiving standard therapy.

GSK today announced it has submitted a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for PRIORIX (Measles, Mumps, and Rubella Virus Vaccine, Live) and is seeking approval for use in active immunization against infection by measles, mumps and rubella (MMR).

ParaPRO, a specialty pharmaceutical company focused on innovative anti-parasitic treatments, today announced the availability of Natroba™ (spinosad) Topical Suspension, 0.9%, the first product (new drug application) for scabies to be approved by the U.S. Food and Drug Administration (FDA) in more than 30 years.

MediWound Ltd., a fully integrated biopharmaceutical company focused on next-generation bio-therapeutic solutions for tissue repair and regeneration, announced that the Company will release its financial results for the second quarter ended June 30, 2021 at 7:00 am Eastern Time on Tuesday, August 10, 2021.

Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, announced that it has granted inducement awards to two new non-executive employees.

SI-BONE, Inc., a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced that Anthem, Inc. will cover minimally invasive SI joint fusion exclusively when performed with the iFuse system of triangular titanium implants.

Cytokinetics, Incorporated announced that on July 30, 2021 it granted stock options to purchase an aggregate of 258,750 shares of common stock to 15 new employees, whose employment commenced in July 2021, as a material inducement to their employment.